ResidualPlaybeta

Batman: The Enemy Within - The Telltale Series

Telltale · 2017 · $14.99 · Adventure · deal grade A

  • Estimated net residual revenue: $4.9k to $7.3k per month
  • Opportunity: $12.9k per month at x2.10 dormancy
  • Estimated lifetime owners: 485.2k
  • 92%% positive across 10647 reviews · 76.0 reviews/month

Why it's flagged

  • Developer silent for 6.5 years
  • Studio quiet across its whole catalog
  • Last build shipped 6.8 years ago
  • Last discounted 0 months ago, 9 sales in the last 12 months
  • Proven demand elasticity: x1.4 review velocity during past deep sales

Analyst notes (AI-assisted)

Telltale's 2017 narrative adventure sequel where player choices shape John Doe's transformation into the Joker, praised for emotional storytelling and consequence-driven branching.

Batman: The Enemy Within remains Telltale's strongest performer in a fading studio catalog, generating $6.1k/mo in residual revenue on modest ongoing discounting and 76 reviews per month. The 92% positive score and franchise appeal suggest stable evergreen demand, but the IP is wholly owned by DC/Warner Bros., making acquisition impossible; the realistic play is licensing negotiation with rights holders to fund a spiritual successor or revival under new stewardship. Most realistic play: licensing.

  • Risk: Full Batman IP control rests with DC Entertainment and Warner Bros.; any revival, sequel, or sequel-like project requires separate licensing approval regardless of who acquires the Telltale catalog.
  • Risk: Telltale's proprietary engine and toolchain are legacy; rebuilding or extending this franchise on modern tech would require substantial rearchitecture rather than patching.
  • Risk: Player sentiment expresses hunger for a third season that Telltale can no longer deliver; demand may atrophy if the studio collapses entirely or if a new IP holder declines continuation.

This case as Markdown · Estimates carry ±30-50%% error per title.